Page last updated: 2024-10-22

alendronate and Osteitis Fibrosa Cystica

alendronate has been researched along with Osteitis Fibrosa Cystica in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Osteitis Fibrosa Cystica: A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benhalima, K1
Katrien, B1
Mertens, A1
Ann, M1
Van den Bruel, A1
Annick, Vd1
Laga, K1
Katrien, L1
Vanderschueren, D1
Dirk, V1
Samson, I1
Ignace, S1
Van Damme, B1
Boudewijin, VD1
Bouillon, R1
Roger, B1
Rubin, MR1
Livolsi, VA1
Bandeira, F1
Caldas, G1
Bilezikian, JP1

Other Studies

2 other studies available for alendronate and Osteitis Fibrosa Cystica

ArticleYear
A brown tumor after biliopancreatic diversion for severe obesity.
    Endocrine journal, 2009, Volume: 56, Issue:2

    Topics: Alendronate; Biliopancreatic Diversion; Bone Density; Calcifediol; Calcium; Female; Humans; Hyperpar

2009
Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11

    Topics: Adult; Alendronate; Biomarkers; Bone Neoplasms; Diagnosis, Differential; Hormone Replacement Therapy

2001